Gracell Biotechnologies Inc.: cash_and_restricted_cash
| Value | {"amount": 210904000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | superseded |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/701a6c6a-aa7b-4463-9aca-eb0433d42f84
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-049599Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/cash-and-restricted-cash/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/701a6c6a-aa7b-4463-9aca-eb0433d42f84
History
- supersedes {"unit": "CNY", "value": 1454645000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"} (evidence 0001104659-23-049599)